Protagonist Therapeutics, Inc Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Protagonist Therapeutics, Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Protagonist Therapeutics, Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $696K, a 3.26% increase year-over-year.
  • Protagonist Therapeutics, Inc annual Operating Lease, Payments for 2023 was $2.74M, a 3.08% increase from 2022.
  • Protagonist Therapeutics, Inc annual Operating Lease, Payments for 2022 was $2.66M, a 29.9% increase from 2021.
  • Protagonist Therapeutics, Inc annual Operating Lease, Payments for 2021 was $2.05M, a 5.56% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.74M +$82K +3.08% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $2.66M +$612K +29.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $2.05M +$108K +5.56% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $1.94M +$56K +2.97% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 $1.89M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.